Further, our studies show that NOTCH1 depletion or treatment with γ-secretase inhibitors reverse resistance in multiple gefitinib-resistant lung cancer cells (Figs 6, 7), suggesting a strong translational potential of our above mechanistic findings. Here, NOTCH1 is linked to lung carcinoma.